Brefonalol

Brefonalol is a pharmacological agent that acts as a beta-adrenergic antagonist, also commonly referred to as a beta-blocker. Beta-adrenergic antagonists are a class of drugs that impede the activation of beta-adrenoceptors by endogenous catecholamines, thus affecting the heart, blood vessels, and various other tissues.
Pharmacology[edit]
Mechanism of Action[edit]
Brefonalol, like other beta-blockers, exerts its therapeutic effects by blocking the activation of beta-adrenoceptors. By doing so, it counteracts the stimulatory effects of neurotransmitters like adrenaline and noradrenaline, leading to decreased heart rate, blood pressure, and workload on the heart.
Therapeutic Uses[edit]
While Brefonalol has potential therapeutic properties similar to other beta-blockers, the specific indications for its use would depend on clinical trials and regulatory approvals.
Typically, beta-blockers are prescribed for:
- Hypertension (high blood pressure)
- Angina pectoris (chest pain)
- Arrhythmia (irregular heartbeats)
- Heart failure management
- Protection after a heart attack
- Migraine prophylaxis
Side Effects[edit]
Beta-adrenergic antagonists, including Brefonalol, can have various side effects due to their action on the cardiovascular system and other organs. Commonly reported side effects may include:
- Fatigue
- Cold extremities
- Slow heart rate (bradycardia)
- Depression
- Sleep disturbances
- Nausea
Contraindications[edit]
Patients with certain medical conditions should exercise caution or avoid the use of Brefonalol:
- Severe asthma or chronic obstructive pulmonary disease (COPD)
- Certain heart conditions like severe bradycardia or heart block
- Severe heart failure
Pharmacokinetics[edit]
The absorption, distribution, metabolism, and excretion of Brefonalol would be key considerations for determining its dosing regimen, drug interactions, and potential toxicities.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
